These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 19509237)
1. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237 [TBL] [Abstract][Full Text] [Related]
2. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Shao L; Cui Y; Li H; Liu Y; Zhao H; Wang Y; Zhang Y; Ng KM; Han W; Ma D; Tao Q Clin Cancer Res; 2007 Oct; 13(19):5756-62. PubMed ID: 17908965 [TBL] [Abstract][Full Text] [Related]
3. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer. Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma. Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676 [TBL] [Abstract][Full Text] [Related]
5. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776 [TBL] [Abstract][Full Text] [Related]
6. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168 [TBL] [Abstract][Full Text] [Related]
7. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418 [TBL] [Abstract][Full Text] [Related]
8. Frequent alteration of XAF1 in human colorectal cancers: implication for tumor cell resistance to apoptotic stresses. Chung SK; Lee MG; Ryu BK; Lee JH; Han J; Byun DS; Chae KS; Lee KY; Jang JY; Kim HJ; Chi SG Gastroenterology; 2007 Jun; 132(7):2459-77. PubMed ID: 17570219 [TBL] [Abstract][Full Text] [Related]
9. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth. Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Lee KY; Geng H; Ng KM; Yu J; van Hasselt A; Cao Y; Zeng YX; Wong AH; Wang X; Ying J; Srivastava G; Lung ML; Wang LD; Kwok TT; Levi BZ; Chan AT; Sung JJ; Tao Q Oncogene; 2008 Sep; 27(39):5267-76. PubMed ID: 18469857 [TBL] [Abstract][Full Text] [Related]
12. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas. Wen XZ; Akiyama Y; Baylin SB; Yuasa Y Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression. Lodygin D; Diebold J; Hermeking H Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of protein kinase D1 in gastric cancer and its role in gastric cancer cell migration and invasion. Kim M; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Norman JC; Caswell PT; Kang GH; Kim SY; Yoo HS; Kim YS Carcinogenesis; 2008 Mar; 29(3):629-37. PubMed ID: 18283041 [TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
16. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Liang G; Robertson KD; Talmadge C; Sumegi J; Jones PA Cancer Res; 2000 Sep; 60(17):4907-12. PubMed ID: 10987305 [TBL] [Abstract][Full Text] [Related]
17. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Miotto E; Sabbioni S; Veronese A; Calin GA; Gullini S; Liboni A; Gramantieri L; Bolondi L; Ferrazzi E; Gafà R; Lanza G; Negrini M Cancer Res; 2004 Nov; 64(22):8156-9. PubMed ID: 15548679 [TBL] [Abstract][Full Text] [Related]
18. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage. Zhang Q; Ying J; Li J; Fan Y; Poon FF; Ng KM; Tao Q; Jin J J Urol; 2010 Aug; 184(2):731-7. PubMed ID: 20639048 [TBL] [Abstract][Full Text] [Related]
19. CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha. Guo X; Li T; Wang Y; Shao L; Zhang Y; Ma D; Han W Biochem Biophys Res Commun; 2009 Sep; 387(1):139-42. PubMed ID: 19577543 [TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas. Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]